









Markets
/
Stocks
/
nasdaq-gsk
/

GSK plc

GSK

View Detailed Chart

37.735USD

-1.235-3.17%

Market hours （ET）Quotes delayed by 15 min

78.21BMarket Cap

19.65P/E TTM



GSK plc

37.735

-1.235-3.17%

Overview Company Financials

Financials

Intraday

30m

Today

-3.17%

5 Days

-0.78%

1 Month

-1.73%

6 Months

+6.72%

Year to Date

+11.58%

1 Year

-5.12%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 10 analysts

HOLD

Current Rating

38.824

Target Price

-0.38%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

172

Total

Median

Average

Company name

Ratings

Analysts

GSK plc

GSK

Biogen Inc

BIIB

Vertex Pharmaceuticals Inc

VRTX

Alnylam Pharmaceuticals Inc

ALNY

Amgen Inc

AMGN

Gilead Sciences Inc

GILD

...

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Neutral

Sell(5)

Neutral(2)

Buy(5)

Indicators

Sell(1)

Neutral(2)

Buy(3)

Indicators

Value

Direction

MACD(12,26,9)

0.286

Neutral

RSI(14)

55.546

Neutral

STOCH(KDJ)(9,3,3)

78.583

Buy

ATR(14)

1.064

Low Volatility

CCI(14)

116.593

Buy

Williams %R

5.249

Overbought

TRIX(12,20)

-0.176

Sell

StochRSI(14)

100.000

Buy

Moving Average

Sell(4)

Neutral(0)

Buy(2)

Indicators

Value

Direction

MA5

38.058

Sell

MA10

37.432

Buy

MA20

37.949

Sell

MA50

39.002

Sell

MA100

38.348

Sell

MA200

36.968

Buy

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

GSK plc is a global biopharma company. The Company’s segments include Commercial Operations and Research and Development. Its portfolio and pipeline are focused on developing medicines and vaccines in four core therapeutic areas, which are the areas of human health it focuses on to prevent and treat disease: respiratory, immunology and inflammation; oncology; HIV; and infectious diseases. Its specialty medicines prevent and treat diseases, from human immunodeficiency virus (HIV) to respiratory diseases, immune-mediated conditions like lupus, and cancer. Its vaccine portfolio includes over 20 vaccines to protect people from a range of diseases and infections throughout their lives. General medicines include inhaled medicines for asthma and COPD, antibiotics and medicines for skin diseases. Its portfolio also includes Efimosfermin, a fibroblast growth factor 21 (FGF21) analog therapeutic in clinical development for the treatment of metabolic dysfunction-associated steatohepatitis (MASH).

Ticker SymbolGSK

CompanyGSK plc

CEOMs. Deborah Waterhouse

Websitehttps://www.gsk.com/